I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Falette-Puisieux, Manon
13
results:
Search for persons
X
Format
Online (13)
Mediatypes
Articles (Online) (9)
OpenAccess-fulltext (4)
Sorted by: Relevance
Sorted by: Year
?
1
Beyond atezolizumab plus bevacizumab in patients with advan..:
Falette-Puisieux, Manon
;
Nault, Jean-Charles
;
Bouattour, Mohamed
...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023
Link:
https://doi.org/10.1177/..
?
2
Beyond atezolizumab plus bevacizumab in patients with advan..:
Falette-Puisieux, Manon
;
Nault, Jean-Charles
;
Bouattour, Mohamed
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399252/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
3
Therapeutic Management of Advanced Hepatocellular Carcinoma..:
Falette Puisieux, Manon
;
Pellat, Anna
;
Assaf, Antoine
...
Cancers. 14 (2022) 10 - p. 2357 , 2022
Link:
https://doi.org/10.3390/..
?
4
Beyond atezolizumab plus bevacizumab in patients with advan..:
Manon Falette-Puisieux
;
Jean-Charles Nault
;
Mohamed Bouattour
...
https://doi.org/10.1177/17588359231189425. , 2023
Link:
https://doi.org/10.1177/..
?
5
Therapeutic Management of Advanced Hepatocellular Carcinoma..:
Manon Falette Puisieux
;
Anna Pellat
;
Antoine Assaf
...
https://dx.doi.org/10.3390/cancers14102357. , 2022
Link:
https://doi.org/10.3390/..
?
6
Therapeutic Management of Advanced Hepatocellular Carcinoma..:
Manon Falette Puisieux
;
Anna Pellat
;
Antoine Assaf
...
https://www.mdpi.com/2072-6694/14/10/2357. , 2022
Link:
https://doi.org/10.3390/..
?
7
A p21/WAF1 mutation favors the appearance of drug resistanc..:
Galmarini, Carlos María
;
Bouchet, Benjamin Pierre
;
Audoynaud, Carole
...
International Journal of Cancer. 119 (2006) 1 - p. 60-66 , 2006
Link:
https://doi.org/10.1002/..
?
8
Influence of p53 and p21WAF1 expression on sensitivity of c..:
Galmarini, Carlos Marı́a
;
Voorzanger, Nathalie
;
Falette, Nicole
...
Biochemical Pharmacology. 65 (2003) 1 - p. 121-129 , 2003
Link:
https://doi.org/10.1016/..
?
9
The human BTG2/TIS21/PC3 gene: genomic structure, transcrip..:
Duriez, Cyril
;
Falette, Nicole
;
Audoynaud, Carole
...
Gene. 282 (2002) 1-2 - p. 207-214 , 2002
Link:
https://doi.org/10.1016/..
?
10
Inactivation of wild-type p53 by a dominant negative mutant..:
Galmarini, C M
;
Falette, N
;
Tabone, E
...
British Journal of Cancer. 85 (2001) 6 - p. 902-908 , 2001
Link:
https://doi.org/10.1054/..
?
11
Expression of a non‐functional p53 affects the sensitivity ..:
Galmarini, Carlos María
;
Clarke, Marilyn L.
;
Falette, Nicole
...
International Journal of Cancer. 97 (2001) 4 - p. 439-445 , 2001
Link:
https://doi.org/10.1002/..
?
12
BTG gene expression in the p53-dependent and -independent c..:
Cortes, Ulrich
;
Moyret-Lalle, Caroline
;
Falette, Nicole
...
Molecular Carcinogenesis. 27 (2000) 2 - p. 57-64 , 2000
Link:
https://doi.org/10.1002/..
?
13
Identification of BTG2, an antiproliferative p53–dependent ..:
Rouault, Jean-Pierre
;
Falette, Nicole
;
Guéhenneux, Fabienne
...
Nature Genetics. 14 (1996) 4 - p. 482-486 , 1996
Link:
https://doi.org/10.1038/..
1-13
